Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 653 participants.

Also called NCT01296412

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 653 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01296412
Other papers using this trial's data
  • Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial Diabetologia, 2013-07 DOI, PubMed 23604551

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01296412. Randomized; no masking; primary purpose treatment. Start 2011-03-11 (actual); primary completion 2012-02-29 (actual). Results posted on 2013-03-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
sitagliptin
Intervention (Drug)
liraglutide
Intervention (Drug)
glimepiride
Intervention (Drug)
metformin
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)

Record details

Record id
cardio:ct-nct01296412
Content hash
51c5fb1b8b01e8143f68f924915e2a7499a4582c93ee95f03b075c40aadb1765